Fig. 5
From: Advances of radiolabeled GRPR ligands for PET/CT imaging of cancers
Decay-corrected whole-body coronal microPET images of T47D (T) and MDA-MB-435 (M) tumor-bearing mice at 30 min, 1 h, 2 h, 4 h, and 24 h after injecting 3.7 ~ 5.5 MBq (100 ~ 150 μCi) of 64Cu-NOTA-RGD-BBN, 18F-FB-PEG3-RGD-BBN or 68Ga-NOTA-RGD-BBN. Images shown are static scans of a single mouse, which is representative of the 4 mice tested in each group. Arrows indicate the presence of T47D (T) or MDA-MB-435 (M) tumors. Reprinted (adapted) with permission from {Liu, Z., et al., (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer. Bioconjug Chem, 2009. 20(5): p. 1016–25.}. Copyright {2009} American Chemical Society